Radiation Oncology/Therapy: Page 201

Semiautomated CT lesion analysis saves time
By Erik L. Ridley
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG18-08 | Room S104AA team from the U.S. National Institutes of Health (NIH) has found that a semiautomated lesion management application was faster and more consistent than manual observers in assessing cancer therapy response.
November 11, 2012
Method segments functional, anatomic areas on PET/MRI
By Erik L. Ridley
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG09-08 | Room S402ABA team from the U.S. National Institutes of Health will present a segmentation method that can simultaneously and automatically delineate regions of radiotracer uptake and corresponding anatomical structures on PET/MRI scans.
November 11, 2012
Semiautomated assessment tool evaluates tumor burden
By Erik L. Ridley
Tuesday, November 27 | 11:30 a.m.-11:40 a.m. | SSG09-07 | Room S402ABResearchers from the U.S. National Institutes of Health will present the results of a semiautomated metastatic lesion measurement tool for providing tumor assessment in melanoma patients.
November 11, 2012
Computer reasoning may improve cancer treatment assessment
By Erik L. Ridley
Tuesday, November 27 | 11:10 a.m.-11:20 a.m. | SSG09-05 | Room S402ABIn this Tuesday morning presentation, Stanford University researchers will discuss their approach to automate and reduce variation in imaging assessment of treatment response.
November 11, 2012
Lesion tracking tool boosts efficiency in RECIST assessments
By Erik L. Ridley
Monday, November 26 | 11:10 a.m.-11:20 a.m. | SSC08-05 | Room S402ABA study team will describe how an automated lesion tracking tool improves radiologist efficiency for quantitative assessment of cancer response on CT studies.
November 11, 2012
PET/MRI tops PET/CT in abdominopelvic lesion conspicuity
By Wayne Forrest
Wednesday, November 28 | 11:50 a.m.-12:00 p.m. | SSK08-09 | Room S504CDPET/MRI with ultrafast gradient-recalled echo and spin-echo sequences is superior to PET/CT for lesion conspicuity, thus potentially improving therapy for patients with abdominopelvic cancer, according to a study by Swiss researchers.
November 7, 2012
FDG-PET/CT helps assess pancreatic cancer recurrence
By Wayne Forrest
Wednesday, November 28 | 11:30 a.m.-11:40 a.m. | SSK13-07 | Room S505ABFDG-PET/CT has "excellent accuracy" in detecting a recurrence following resection of pancreatic cancer, and maximum standardized uptake values can be used in determining the prognosis of these patients, according to researchers from India.
November 7, 2012
FDG-PET/CT plays key role in treatment outcomes of prostate cancer
By Wayne Forrest
Wednesday, November 28 | 11:00 a.m.-11:10 a.m. | SSK13-04 | Room S505ABA preliminary study by researchers at the University of Southern California suggests that FDG-PET/CT provides unique prognostic information on outcomes for men with castrate-sensitive metastatic prostate cancer who are undergoing various forms of hormonal treatment.
November 7, 2012
PET/MRI outshines PET/CT in lesion detection
By Wayne Forrest
Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC13-04 | Room S505ABPET/MRI showed superior lesion detectability compared to contrast-enhanced PET/CT in this study from King Fahad Specialist Hospital in Dammam, Saudi Arabia. Based on the results, researchers concluded that PET/MRI may be useful for abdominal lesion staging while sparing patients from contrast media.
November 7, 2012
NaF-PET/CT detects more skeletal lesions in advanced breast cancer cases
By Wayne Forrest
Monday, November 26 | 11:00 a.m.-11:10 a.m. | SSC09-04 | Room S504CDF-18 sodium fluoride (NaF) PET/CT detects more skeletal lesions than technetium-99m methylene diphosphonate SPECT in patients newly diagnosed with breast cancer, according to researchers from India.
November 7, 2012
FDG-PET/CT predicts response to chemo in breast cancer patients
By Wayne Forrest
Sunday, November 25 | 11:55 a.m.-12:05 p.m. | SSA18-08 | Room S505ABIn this presentation, Japanese researchers will discuss the ability of FDG tumor uptake at baseline and after neoadjuvant chemotherapy to predict pathological complete response and disease-free survival after surgery.
November 7, 2012
PET/CT helps with bone scans in staging breast cancer
By Wayne Forrest
Sunday, November 25 | 11:45 a.m.-11:55 a.m. | SSA18-07 | Room S505ABPET/CT can provide sufficient information from bone scans for the staging or restaging of breast cancer, according to a retrospective study by researchers from University Hospital Mannheim.
November 7, 2012
Previous Page
Page 201 of 467
Next Page